Rafina Innovations Inc. Receivables Turnover Ratio (VICA), from the first quarter 2019 to the first quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Rafina Innovations Inc.  (VICA)
 

Rafina Innovations Accounts Receivables Turnover Ratio from the first quarter 2019 to the first quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Rafina Innovations Inc.'s ability to collect accounts receivable sequentially worsen to 2.37, indicating more challenging environment then in the fourth quarter 2018, but still, it is a far cry from any concerns. Rafina Innovations's Accounts Receivable average collection period in the Mar 31 2019 quarter, has increased to 154 days, from 124 days, in the Dec 31 2018 quarter.

If we take a look into Healthcare sector 91 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1087, from overall ranking in the fourth quarter 2018 at 3657.

What is Receivable Turnover Ratio?
What is Rafina Innovations Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VICA Receivables Turnover Ratio (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter
Y / Y Receivable Change 5 % 83.8 % 54.01 % 42.69 % 112.24 %
Y / Y Revenue Change -58.83 % 1.87 % 81.55 % -23.23 % 52.45 %
Receivable Turnover Ratio (TTM) 2.37 2.95 3.38 3.38 4.02
VICA's Total Ranking # 1087 # 3657 # 3636 # 3125 # 1087
Accounts Receivable average collection period days 154 124 108 108 91
Seq. Receivable Change -13.7 % 15.1 % 9.19 % -3.19 % 51.07 %
Seq. Revenue Change -37.95 % -4.11 % -10.88 % -22.37 % 53.56 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 39
Healthcare Sector # 92
Overall Market # 1087

Receivable Turnover Ratio Statistics
High Average Low
1.82 0.85 -0.01
(Jun 30 2017)   (Jun 30 2015)





VICA Company Profile • Back to VICA Efficiency Comparisons • Compare VICA Receivables Turnover Ratio to its Competitors

Financial Statements
Rafina Innovations's Accounts Receivable $ 0 Millions Visit VICA's Balance sheet
Rafina Innovations's Sales TTM $ 0 Millions Visit VICA's Income Statement
Sources of VICA's Revenues Visit VICA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VICA's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VICA's Growth Rates VICA's Roa VICA's Inventory Turnover Ratio VICA's Dividend Comparisons
VICA's Profitability Ratios VICA's Roi VICA's Asset Turnover Ratio VICA's Dividend Growth
VICA's Valuation Ratios VICA's Roe VICA's Financial Strength Ratios VICA's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2019 Receivable at quarter ending Mar 31 2019
Amgen Inc   6.65 $ 23,750.000  Millions$ 3,574.000  Millions
Cytosorbents Corporation  6.62 $ 22.771  Millions$ 3.439  Millions
Standard Biotools Inc   6.62 $ 117.827  Millions$ 17.803  Millions
Amphastar Pharmaceuticals Inc   6.58 $ 316.063  Millions$ 48.047  Millions
Cardax Inc   6.58 $ 1.363  Millions$ 0.207  Millions
Intuitive Surgical Inc   6.57 $ 3,850.400  Millions$ 585.700  Millions
Prestige Consumer Healthcare Inc   6.57 $ 975.777  Millions$ 148.477  Millions
Gilead Sciences Inc   6.56 $ 22,320.000  Millions$ 3,404.000  Millions
Meridian Bioscience Inc   6.56 $ 206.565  Millions$ 31.504  Millions
Cormedix Inc   6.50 $ 0.570  Millions$ 0.088  Millions
Agilent Technologies inc   6.47 $ 5,019.000  Millions$ 776.000  Millions
Fuse Medical Inc   6.47 $ 25.109  Millions$ 3.882  Millions
Champions Oncology Inc   6.46 $ 27.067  Millions$ 4.192  Millions
Opko Health Inc   6.40 $ 957.803  Millions$ 149.610  Millions
Invitae Corporation  6.39 $ 160.581  Millions$ 25.136  Millions
Axogen inc   6.33 $ 89.963  Millions$ 14.216  Millions
Stryker Corp  6.32 $ 13,876.000  Millions$ 2,195.250  Millions
Societal Cdmo Inc   6.31 $ 82.870  Millions$ 13.125  Millions
Scientific Industries Inc   6.31 $ 10.464  Millions$ 1.659  Millions
Ufp Technologies Inc   6.30 $ 194.852  Millions$ 30.947  Millions
Harvard Bioscience Inc   6.29 $ 122.217  Millions$ 19.431  Millions
Merit Medical Systems Inc  6.28 $ 918.067  Millions$ 146.213  Millions
Radnet Inc   6.26 $ 965.728  Millions$ 154.186  Millions
Pro dex Inc   6.26 $ 26.418  Millions$ 4.220  Millions
Nanostring Technologies Inc   6.25 $ 111.335  Millions$ 17.819  Millions
Qc Technologies Inc   6.24 $ 1.975  Millions$ 0.317  Millions
Tactile Systems Technology Inc   6.22 $ 154.520  Millions$ 24.828  Millions
Aytu Biopharma Inc  6.22 $ 6.530  Millions$ 1.049  Millions
Boston Scientific Corporation  6.22 $ 9,938.000  Millions$ 1,599.000  Millions
Arcturus Therapeutics Holdings Inc   6.21 $ 17.736  Millions$ 2.858  Millions

Date modified: 2026-09-08T15:09:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.